Ergomed PLC
LSE:ERGO

Watchlist Manager
Ergomed PLC Logo
Ergomed PLC
LSE:ERGO
Watchlist
Price: 1 346 GBX Market Closed
Market Cap: 701.1m GBX
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of ERGO.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ERGO Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

4.5
P/S
P/S
Price to Sales
4.5
vs History
vs Industry
Median 3Y
4.5
Median 5Y
4.5
Industry
3.6
Forward
4.1
More Details
45.6
P/E
P/E
Price to Earnings
45.6
vs History
vs Industry
Median 3Y
45.6
Median 5Y
45.6
Industry
28.6
Forward
28.5
More Details
35.5
P/OCF
P/OCF
Price to OCF
35.5
vs History
vs Industry
Median 3Y
35.5
Median 5Y
35.4
Industry
18.9
More Details
49
P/FCFE
P/FCFE
Price to FCFE
49
vs History
vs Industry
Median 3Y
49
Median 5Y
46.2
Industry
28.6
More Details
7.5
P/B
P/B
Price to Book Value
7.5
vs History
vs Industry
Median 3Y
7.5
Median 5Y
7.5
Industry
2.3
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
vs Industry
Median 3Y
4.3
Median 5Y
4.3
Industry
3.3
Forward
4
More Details
10.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
10.6
vs History
vs Industry
Median 3Y
10.7
Median 5Y
10.7
Industry
7.6
More Details
25.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.1
vs History
vs Industry
Median 3Y
25.1
Median 5Y
25.1
Industry
16.1
Forward
19.9
More Details
31.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
31.8
vs History
vs Industry
Median 3Y
31.8
Median 5Y
31.8
Industry
21
Forward
23.7
More Details
34.2
EV/OCF
EV/OCF
Enterprise Value to OCF
34.2
vs History
vs Industry
Median 3Y
34.2
Median 5Y
34.2
Industry
18
More Details
39.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
39.2
vs History
vs Industry
Median 3Y
39.2
Median 5Y
38.4
Industry
20.4
More Details
6.4
EV/IC
EV/IC
Enterprise Value to IC
6.4
vs History
vs Industry
Median 3Y
6.4
Median 5Y
6.4
Industry
2.1
More Details

Multiples Across Competitors

ERGO Competitors Multiples
Ergomed PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Ergomed PLC
LSE:ERGO
683.5m GBP 4.5 45.6 25.1 31.8
US
PerkinElmer Inc
LSE:0KHE
1T USD 376.8 3 839.3 1 225.2 2 470.1
US
Thermo Fisher Scientific Inc
NYSE:TMO
160.1B USD 3.7 24.6 19.7 23.7
US
Danaher Corp
NYSE:DHR
141.1B USD 5.9 37.5 20.6 30
KR
Samsung Biologics Co Ltd
KRX:207940
71.2T KRW 15.7 65.7 36.9 53.7
CH
Lonza Group AG
SIX:LONN
40.1B CHF 6.1 63 23.1 36
US
Agilent Technologies Inc
NYSE:A
30.3B USD 4.6 24.1 17.7 20.7
US
IQVIA Holdings Inc
NYSE:IQV
26.5B USD 1.7 19.3 11.1 16.5
CN
WuXi AppTec Co Ltd
SSE:603259
165.7B CNY 4.2 17.5 13.8 13.8
US
Mettler-Toledo International Inc
NYSE:MTD
22.2B USD 5.7 25.8 19.1 21.2
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.6B EUR 6.9 95.8 30.5 54

See Also

Summary
ERGO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ERGO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ERGO stock valuation using valuation multiples.
Wall Street Estimates
ERGO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ERGO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.